RESUMO
HIGHLIGHT: The body of knowledge needed to effectively practice travel medicine has expanded since the 1990s, as migrants begin to comprise an increasing proportion of the world's population. We describe the unique needs of migrants and provide resources available to migration health practitioners. As the number of the world's migrants grows, collaboration across disciplines is key to achieving high-quality migration health practices.
Assuntos
Dinâmica Populacional/tendências , Migrantes/estatística & dados numéricos , Medicina de Viagem/tendências , Viagem/tendências , Países Desenvolvidos/estatística & dados numéricos , Países em Desenvolvimento/estatística & dados numéricos , Saúde Global , HumanosRESUMO
OBJECTIVE: Colleges are at risk for communicable disease outbreaks because of the high degree of person-to-person interactions and relatively crowded dormitory settings. This report describes the US college student health screening requirements among US resident and international students for tuberculosis (TB) and vaccine-preventable diseases (VPDs) as they relate to the American College Health Association (ACHA) guidelines. Methods/Participants: In April 2012, US college health administrators (N = 2,858) were sent online surveys to assess their respective school's TB screening and immunization requirements. RESULTS: Surveys were completed by 308 (11%) schools. Most schools were aware of the ACHA immunization (78%) and TB screening (76%) guidelines. Schools reported having policies related to immunization screening (80.4%), immunization compliance (93%), TB screening (55%), and TB compliance (87%). CONCLUSION: Most colleges were following ACHA guidelines. However, there are opportunities for improvement to fully utilize the recommendations and prevent outbreaks of communicable diseases among students in colleges.
Assuntos
Surtos de Doenças/prevenção & controle , Programas de Rastreamento/legislação & jurisprudência , Estudantes , Tuberculose/diagnóstico , Vacinação/estatística & dados numéricos , Surtos de Doenças/estatística & dados numéricos , Feminino , Política de Saúde/legislação & jurisprudência , Humanos , Masculino , Serviços de Saúde para Estudantes/métodos , Serviços de Saúde para Estudantes/estatística & dados numéricos , Inquéritos e Questionários , Universidades/organização & administraçãoRESUMO
Kevin Cain and colleagues reflect on the cross border movement of people from Somalia with MDR-TB and the implications for MDR-TB programs in East Africa.
Assuntos
Antituberculosos , Emigração e Imigração , Epidemias , Necessidades e Demandas de Serviços de Saúde , Mycobacterium tuberculosis , Tuberculose Resistente a Múltiplos Medicamentos , Tuberculose Pulmonar , África Oriental/epidemiologia , Humanos , Refugiados , Somália/epidemiologia , Tuberculose Resistente a Múltiplos Medicamentos/epidemiologia , Tuberculose Resistente a Múltiplos Medicamentos/microbiologia , Tuberculose Resistente a Múltiplos Medicamentos/terapia , Tuberculose Pulmonar/epidemiologia , Tuberculose Pulmonar/microbiologia , Tuberculose Pulmonar/terapiaRESUMO
BACKGROUND: In-flight transmission risk of Mycobacterium tuberculosis is not well defined, although studies suggest it is low. The impact of flight-related tuberculosis (TB) contact investigations (TBCIs) on TB prevention and control is not well established, and they compete for resources with activities with established benefits. We sought to determine the risks and cost-benefits of using more restrictive criteria in comparison to the Centers for Disease Control and Prevention (CDC) 2008 protocol for TBCIs. METHODS: The risk-benefits of a modified CDC protocol were analyzed in comparison to the 2008 CDC protocol using data from flight-related TBCIs conducted in the United States from 2007 through 2009. We predicted the numbers and characteristics of case-travelers that would be identified using each protocol's criteria, and results of the associated passenger-contacts' TB screening tests. The economic analysis compared the costs of TBCIs to avoided costs of TB treatment and mortality using a Return on Investment model. RESULTS: The estimated in-flight transmission risk using a modified CDC protocol was 1.4%-19% versus 1.1%-24% for the 2008 protocol. Numbers of TBCIs and immediate costs to health departments were reduced by half. Long-term cost-benefits were comparable. CONCLUSIONS: CDC's modified protocol appears to be a feasible alternative that will conserve public health resources without jeopardizing the public's health.
Assuntos
Viagem Aérea , Busca de Comunicante/economia , Busca de Comunicante/métodos , Tuberculose/transmissão , Centers for Disease Control and Prevention, U.S. , Análise Custo-Benefício , Humanos , Medição de Risco , Medicina de Viagem , Tuberculose/epidemiologia , Estados Unidos/epidemiologiaRESUMO
BACKGROUND: In 2011, the Centers for Disease Control and Prevention modified its 2008 protocol for flight-related tuberculosis contact investigation initiation. The 2011 Modified protocol was implemented and replaced the 2008 CDC protocol based on comparative epidemiologic and economic analyses; this publication reports the economic analysis results. METHODS: A return on investment model compared relative changes in tuberculosis disease treatment costs resulting from expenditures on tuberculosis contact investigations and latent tuberculosis infection treatment for the 2008 CDC and Modified protocols. RESULTS: At moderate/high rates of latent tuberculosis infection and tuberculosis disease, positive returns on investment indicated each $1.00 spent on tuberculosis contact investigations and latent tuberculosis treatment resulted in more than $1.00 of savings from reduced tuberculosis disease treatment costs. Low rates of latent tuberculosis infection and tuberculosis disease resulted in negative returns on investment, indicating economic losses from tuberculosis disease treatment costs. There were smaller economic losses at low latent tuberculosis infection and tuberculosis disease rates with the Modified protocol in comparison to the 2008 CDC protocol, while both identified comparable numbers of persons at risk for tuberculosis. CONCLUSION: The Modified protocol for conducting flight-related tuberculosis contact investigations represents a better use of resources and protects public health.
Assuntos
Viagem Aérea , Busca de Comunicante/economia , Busca de Comunicante/métodos , Tuberculose/economia , Tuberculose/transmissão , Humanos , Tuberculose Latente , Risco , Tuberculose/epidemiologia , Estados Unidos/epidemiologiaRESUMO
We assessed rabies vaccine (RV) and immune globulin (RIG) availability on the local market by querying US Embassy medical staff worldwide. Of 112 responses, 23% were from West, Central, and East Africa. RV and RIG availability varied by region. Possible rabies exposures accounted for 2% of all travelers' health inquiries.
Assuntos
Controle de Doenças Transmissíveis , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Imunoglobulinas , Fatores Imunológicos/provisão & distribuição , Vacina Antirrábica , Raiva , África/epidemiologia , Ásia/epidemiologia , Controle de Doenças Transmissíveis/métodos , Controle de Doenças Transmissíveis/organização & administração , Europa Oriental/epidemiologia , Pesquisas sobre Atenção à Saúde , Humanos , Imunoglobulinas/uso terapêutico , Fatores Imunológicos/uso terapêutico , Sistemas de Medicação/estatística & dados numéricos , Avaliação das Necessidades , Avaliação de Resultados em Cuidados de Saúde , Raiva/epidemiologia , Raiva/prevenção & controle , Vacina Antirrábica/provisão & distribuição , Vacina Antirrábica/uso terapêutico , Programas Médicos Regionais , Viagem , Estados UnidosRESUMO
BACKGROUND: Rabies, which is globally endemic, poses a risk to international travelers. To improve recommendations for travelers, we assessed the global availability of rabies vaccine (RV) and rabies immune globulin (RIG). METHODS: We conducted a 20-question online survey, in English, Spanish, and French, distributed via e-mail to travel medicine providers and other clinicians worldwide from February 1 to March 30, 2011. Results were compiled according to the region. RESULTS: Among total respondents, only 190 indicated that they provided traveler postexposure care. Most responses came from North America (38%), Western Europe (19%), Australia and South and West Pacific Islands (11%), East and Southeast Asia (8%), and Southern Africa (6%). Approximately one third of 187 respondents stated that patients presented with wounds from an animal exposure that were seldom or never adequately cleansed. RIG was often or always accessible for 100% (n = 5) of respondents in the Middle East and North Africa; 94% (n = 17) in Australia and South and West Pacific Islands; 20% (n = 1) in Tropical South America; and 56% (n = 5) in Eastern Europe and Northern Asia. Ninety-one percent (n = 158) of all respondents reported that RV was often or always accessible. For all regions, 35% (n = 58) and 26% (n = 43) of respondents felt that the cost was too high for RIG and RV, respectively. CONCLUSION: The availability of RV and RIG varied by geographic region. All travelers should be informed that RIG and RV might not be readily available at their destination and that travel health and medical evacuation insurance should be considered prior to departure. Travelers should be educated to avoid animal exposures; to clean all animal bites, licks, and scratches thoroughly with soap and water; and to seek medical care immediately, even if overseas.
Assuntos
Mordeduras e Picadas , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Imunização Passiva/métodos , Vacina Antirrábica/uso terapêutico , Raiva , Viagem , Animais , Mordeduras e Picadas/etiologia , Mordeduras e Picadas/terapia , Vetores de Doenças , Doenças Endêmicas , Primeiros Socorros/métodos , Pesquisas sobre Atenção à Saúde , Conhecimentos, Atitudes e Prática em Saúde , Pessoal de Saúde , Humanos , Internacionalidade , Avaliação das Necessidades , Serviços Preventivos de Saúde/métodos , Serviços Preventivos de Saúde/estatística & dados numéricos , Raiva/epidemiologia , Raiva/prevenção & controle , Inquéritos e Questionários , Medicina de Viagem/métodosRESUMO
Shipping companies were surveyed to evaluate the effect of public health measures during the influenza A (H1N1) pandemic of 2009 on ship and port operations. Of 31 companies that operated 960 cruise, cargo, and other ships, 32% experienced health-screening measures by port health authorities. Approximately a quarter of ports (26%) performed screening at embarkation and 77% of shipping companies changed procedures during the early stage of the pandemic. Four companies reported outbreaks of pandemic influenza A (H1N1) 2009 on ships, which were ultimately stopped through infection control practices. Public health measures did not interfere substantially with port and ship operations with the exception of some port authorities that delayed embarking and disembarking procedures in a few ships. However, in the shipping companies' experience, measures were inconsistent between port health authorities. Access to antiviral drugs and pandemic vaccine was not provided in all ports. Current guidelines on medical care, hygiene, and emergency procedures on ships need to address pandemic influenza preparedness in future revisions.
Assuntos
Saúde Global , Controle de Infecções/métodos , Vírus da Influenza A Subtipo H1N1 , Influenza Humana/prevenção & controle , Pandemias/estatística & dados numéricos , Navios , Comportamentos Relacionados com a Saúde , Promoção da Saúde/métodos , Humanos , Influenza Humana/epidemiologia , Saúde Ocupacional , Saúde Pública/métodos , Infecções Respiratórias/epidemiologia , Infecções Respiratórias/prevenção & controle , Inquéritos e Questionários , Fatores de Tempo , Viagem , Medicina de ViagemAssuntos
Política de Saúde , Medição de Risco , Viagem , Febre Amarela , Animais , Humanos , Quênia/epidemiologia , Vigilância de Evento Sentinela , Febre Amarela/epidemiologia , Febre Amarela/prevenção & controle , Vacina contra Febre Amarela/efeitos adversos , Vacina contra Febre Amarela/uso terapêutico , ZoonosesRESUMO
Historically, veterinary medicine has made its greatest contributions in the public sector and in settings other than direct care of the individual patient. So why are so many of us unaware of our profession's achievements in this arena? My introduction to veterinary preventive medicine and public health was through military service. My obligation to serve a two-year doctor draft in the United States Air Force became an adventure for my family and me, rather than an unwelcome intrusion on my ultimate desire to return to private clinical practice. The operative words are private and clinical. Why was I unaware of the opportunities available to those of us educated in this discipline sometimes referred to as comparative medicine?